Lidoflazine

From Self-sufficiency
Revision as of 16:19, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Lidoflazine
File:Lidoflazine.png
Systematic (IUPAC) name
2-[4-[4,4-bis(4-fluorophenyl)butyl]piperazin-1-yl]-N-(2,6-dimethylphenyl)acetamide
Identifiers
CAS Number 3416-26-0
ATC code C08EX01 (WHO)
PubChem CID 3926
Chemical data
Formula C30H35F2N3O
Molar mass 491.615[[Script error: No such module "String".]]
Physical data
Melting point 159 to 161 °C (318 to 322 °F)
Solubility in water Almost insoluble in water(<0.01%); Very soluble in chloroform(>50%); mg/mL (20 °C)
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Lidoflazine is a piperazine calcium channel blocker. It is a coronary vasodilator with some antiarrhythmic action.[1] Lidoflazine was discovered at Janssen Pharmaceutica in 1964.

Physical properties

Solubility at room temperature

Extracted from [2]

Solvent 0.01

N

0.1

N

 % pH  % pH
Hydrochloric Acid 0.4 3.0 0.7 1.9
Tartaric Acid 0.3 3.1 1.0 2.5
Citric Acid 0.3 3.1 0.5 2.5
Lactic Acid 0.2 3.4 0.7 2.9
Acetic Acid 0.1 3.5 0.4 3.8

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />
  • Schaper WK, Xhonneux R, Jageneau AH., Stimulation of the coronary collateral circulation by lidoflazine (R 7904), Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1965 Nov 4;252(1):1-8.


  1. Schaper, W.K.A.; Xhonneux, R.; Jageneau, A.H.M.; Janssen, P.A.J. (1966). "The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator". Journal of Pharmacology and Experimental Therapeutics. 152 (2): 265–274. PMID 5944369. Retrieved 2009-06-20. 
  2. http://jpet.aspetjournals.org/cgi/content/abstract/152/2/265